Skip to main content
. 2025 Aug 15;16:181. doi: 10.1186/s13244-025-02058-7

Table 3.

Predictive imaging markers of surgical resection and transplantation

Treatment Reference Study design No. of patients Follow-up duration Poor predictive imaging finding Primary outcome
Surgical resection Shin et al [63] Retrospective, single-center 281 2 years LR-M compared to LR-4/5, largest tumor size of ≥ 3 cm Early recurrence
Surgical resection Jiang et al [65] Retrospective, single-center 532 1 to 11 years Tumor size, arterial phase hyperenhancement HCC recurrence
Surgical resection Wei et al [38] Retrospective, single-center 103 Median of 22.1 months Corona enhancement, peritumoral hypointensity on hepatobiliary phase, satellite nodule Early recurrence
Surgical resection Wei et al [31] Retrospective, single-center 111 Median of 22.1 months Blood products in mass, corona enhancement Recurrence
Surgical resection Zhang et al [67] Retrospective, single-center 82 1 year Corona enhancement, irregular tumor margin Early recurrence
Surgical resection Chen et al [68] Retrospective, single-center 149 3 years Multifocal tumors, absence of fat in mass, nonsmooth tumor margin Recurrence
Surgical resection Bae et al [39] Retrospective, single-center 183 Median of 51 months Large tumor size on hepatobiliary phase Disease-free survival, overall survival
Liver transplant Lee et al [64] Retrospective, multicenter 140 7 years LR-M compared to LR-4/5 Recurrence-free survival